Answers are grounded in this paper and cite their sources.
The efficacy of antiretroviral medicines (ARVs) for prolonging life of persons living with human immunodeficiency virus (HIV) infection has not been in doubt As the world continues to await a cure for HIV infection, ART remains a life life-long venture but retention in antiretroviral therapy (ART) programs has been a significant challenge to persons receiving ART [2, Many large and small studies have
No takes yet. Share an insight, caveat, or question.
Kweku et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: